Potential Spillover Effects on Diagnostic Delay for Cancer During the NHS-Galleri Trial
This quasi-experimental study found that NHS-Galleri trial regions experienced higher cancer diagnostic delays for high-detection cancer types, raising concerns about spillover that could overestimate the benefit of MCED testing
Source Articles
RAND Corporation (United States) | Apr 20, 2026
Your votes count
No account needed. Your votes are saved and included in the consensus analysis. Create an account to keep a record of your votes.
💡 How this works
- • Add statements: Post claims or questions (10 to 500 characters).
- • Vote: Agree, disagree or unsure on each statement.
- • Respond: Add detailed arguments for or against, with evidence.
- • Consensus: Once enough people take part, analysis shows opinion groups and where they agree.
Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.
Support us